Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 11,230 shares of Fluidigm stock in a transaction on Friday, December 29th. The stock was purchased at an average price of $5.94 per share, for a total transaction of $66,706.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Friday, December 28th, Levin Capital Strategies, L.P. purchased 30 shares of Fluidigm stock. The stock was purchased at an average price of $5.82 per share, for a total transaction of $174.60.
  • On Wednesday, December 27th, Levin Capital Strategies, L.P. bought 27,100 shares of Fluidigm stock. The shares were bought at an average price of $5.88 per share, for a total transaction of $159,348.00.
  • On Friday, December 15th, Levin Capital Strategies, L.P. bought 24,175 shares of Fluidigm stock. The shares were bought at an average price of $5.84 per share, for a total transaction of $141,182.00.
  • On Tuesday, December 12th, Levin Capital Strategies, L.P. bought 18,569 shares of Fluidigm stock. The shares were bought at an average price of $5.84 per share, for a total transaction of $108,442.96.
  • On Monday, December 4th, Levin Capital Strategies, L.P. bought 8,409 shares of Fluidigm stock. The shares were bought at an average price of $5.48 per share, for a total transaction of $46,081.32.
  • On Wednesday, November 29th, Levin Capital Strategies, L.P. bought 20,380 shares of Fluidigm stock. The shares were bought at an average price of $5.71 per share, for a total transaction of $116,369.80.
  • On Friday, November 17th, Levin Capital Strategies, L.P. bought 6,880 shares of Fluidigm stock. The shares were bought at an average price of $5.05 per share, for a total transaction of $34,744.00.
  • On Wednesday, November 8th, Levin Capital Strategies, L.P. bought 54,900 shares of Fluidigm stock. The shares were bought at an average price of $5.26 per share, for a total transaction of $288,774.00.
  • On Wednesday, October 25th, Levin Capital Strategies, L.P. bought 4,227 shares of Fluidigm stock. The shares were bought at an average price of $5.42 per share, for a total transaction of $22,910.34.
  • On Monday, October 23rd, Levin Capital Strategies, L.P. bought 22,363 shares of Fluidigm stock. The shares were bought at an average price of $5.47 per share, for a total transaction of $122,325.61.

Fluidigm Co. (NASDAQ FLDM) opened at $6.55 on Thursday. Fluidigm Co. has a 12-month low of $2.52 and a 12-month high of $8.69. The stock has a market cap of $240.77, a P/E ratio of -2.92 and a beta of 3.37. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02.

Separately, ValuEngine upgraded shares of Fluidigm from a “strong sell” rating to a “sell” rating in a research report on Monday, October 23rd.

Several hedge funds have recently made changes to their positions in the company. Teachers Advisors LLC lifted its position in shares of Fluidigm by 1.8% during the second quarter. Teachers Advisors LLC now owns 56,662 shares of the medical research company’s stock worth $229,000 after purchasing an additional 999 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Fluidigm by 1.5% during the first quarter. Geode Capital Management LLC now owns 218,321 shares of the medical research company’s stock worth $1,242,000 after buying an additional 3,311 shares during the last quarter. Alliancebernstein L.P. raised its stake in shares of Fluidigm by 18.4% during the second quarter. Alliancebernstein L.P. now owns 45,700 shares of the medical research company’s stock worth $185,000 after buying an additional 7,100 shares during the last quarter. PDT Partners LLC raised its stake in shares of Fluidigm by 56.0% during the second quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock worth $110,000 after buying an additional 9,800 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in shares of Fluidigm by 5.5% during the second quarter. Bank of New York Mellon Corp now owns 217,839 shares of the medical research company’s stock worth $880,000 after buying an additional 11,261 shares during the last quarter. Institutional investors own 93.27% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://theolympiareport.com/2018/01/04/levin-capital-strategies-l-p-purchases-11230-shares-of-fluidigm-co-fldm-stock.html.

About Fluidigm

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.